Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.
Priyanka D PatelPratiksha PatelYuanyuan LiangJames E MeiringTheresa MisiriFelistas MwakiseghileJ Kathleen TracyClemens MasesaHarrison MsukuDavid BandaMaurice MbeweMarc Yves Romain HenrionFiyinfolu AdetunjiKenneth SimiyuElizabeth RotrosenMegan BirkholdNginache NampotaOsward M NyirendaKaren KotloffMarkus GmeinerQueen DubeGift KawalaziraMatthew B LaurensRobert S HeydermanMelita A GordonKathleen M Neuzilnull nullPublished in: The New England journal of medicine (2021)
Among Malawian children 9 months to 12 years of age, administration of Vi-TCV resulted in a lower incidence of blood culture-confirmed typhoid fever than the MenA vaccine. (Funded by the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT03299426.).
Keyphrases